drugset / Trial / NCT06892639
Evaluation of D-Fi for the Treatment of Wounds Due to DEB
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether administration of D-Fi in addition to standard of care improves wound healing as compared to standard of care alone (control) in children, adolescents, and adults with Dystrophic Epidermolysis Bullosa.
Timeline
- Start
- 2025-03-27
- Primary completion
- 2027-09
- Completion
- 2042-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dabocemagene Autoficel | Cell therapy | — | Intrathecal |